Low or High Ligation of the IMA With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery

Low or High Ligation of the Inferior Mesenteric Artery With Apical Lymph Node Dissection in Rectal Cancer Laparoscopic Surgery: A Prospective, Multi-Center, Randomized, Open-Label, Parallel Group, Non-Inferiority Clinical Trial (LAND)

Laparoscopy colon surgery is accepted worldwide in the recent years. But there is still argument on the effect of laparoscopy rectal surgery. Laparoscopy has advantages on showing the inferior mesenteric artery (IMA), protection of autonomic nerve, low rectal anastomosis, and total mesorectum excision. However, debate on the level of IMA ligation and debonding of splenic flexure never ends. This study is going to give a clear and definite answer to how and why surgeons should deal with the IMA in laparoscopy rectal surgery,base on the 3D reconstruction of IMA and identification of IMA perfusion types.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

According to the report of World Health Organization 2015, the morbility and mortality of colorectal cancer (CRC) are rising all over the world. Although the technique gets great approval in CRC surgical treatment in the recent years, such as TME protocol, neoadjuvant and laparoscopy technique, the complication of anastomosis leakage and nerve damage are still to be solved.

Laparoscopy colon surgery is accepted worldwide in the recent years. But there is still argument on the effect of laparoscopy rectal surgery. Laparoscopy has advantages on showing the inferior mesenteric artery, protection of autonomic nerve, low rectal anastomosis, and total mesorectum excision. However, debate on where is the best level of IMA ligation and whether splenic flexure be debonded never ends. This study is going to give a clear and definite answer to how and why surgeons should deal with the IMA in laparoscopy rectal surgery.

The ligation level of IMA affects on hypogastric and pelvic nerve, leads to disorder of sexual and urination functions. What's more, it also have affection on the apical lymph node (No.253) harvesting and the blood supplement of proximal colon. Former studies have proved that the blood supplement and tension of anastomosis leads to leakage after surgery. Meanwhile, the ligation level of IMA is the key point on it.

The former study comes from the sixth affiliated hospital found that the mistake of ligation level of IMA happened because of the poor touching and explosion with laparoscopy. The distance from the root of IMA to left colic artery (DRL) vary between 19mm and 64mm. When surgeon made mistake during ligation, it led to the insufficient resection of apical lymph node. Further more, affect the long-term survival. Besides, there are 4 different types of IMA according to the relationship between the left colic artery, sigmoid artery and superior rectal artery. These branches will confuse surgeon on how to deal with them. 3D reconstruction of abdominal pelvic CT is able to show the length of DRL, IMA types and apical lymph nodes clearly. With these technique, the investigators can preserve the left colic artery and resect apical lymph nodes precisely.

In the past studies, high or low ligation takes advantage on both side. But none of them comes from retrospective clinical trail. Some author believe that high ligation do better in resection of apical lymph nodes, release the tension of anastomosis, providing precise tumor staging. On the other side, some authors consider that high ligation may cut down blood supplement, rise the incident of anastomosis leakage (AL). so they prefer low ligation to the high. Some studies show that there are no long term survival difference between high and low ligation on IMA in laparoscopy rectal resection. So whether high ligation is necessary, still to be proved.

For local advanced rectal cancer, neoadjuvant chemotherapy can lesson tumor size, reduce recurrence, preserve annual better and rise long-term survival. National Comprehensive Cancer Network command chemotherapy before surgery (Total Mesorectal Excision TME) as the standard for rectal cancer since 2005. Another randomized controlled trial (RCT) named Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer (FOWARC) NCT01211210 has proved the recent positive result. In those cases, the positive metastasis apical lymph node appeared in less than 5% (5/116) cases. On the other side, the incident of AL was up to 7% (8/116) . This phenomenon discover that maybe low ligation with apical lymph nodes dissection can get the same treatment effect and decrease AL from happening.

Study Type

Interventional

Enrollment (Anticipated)

748

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510655
        • Recruiting
        • The sixth affiliated hospital of Sun Yat-Sen University
        • Contact:
        • Contact:
        • Principal Investigator:
          • Jiaping Wang, MD
        • Sub-Investigator:
          • Jiaming Zhou, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Pathology shows rectal or sigmoid adenocarcinoma
  • The bottom edge of tumor to anuas is less than 15cm
  • The clinical staging of tumor by American Joint Committee on Cancer (AJCC) within T2-4 or N1-2
  • Receive or not receive neoadjuvant chemotherapy based on 5-fluorouracil before surgery
  • Racial resection in available after neoadjuvant chemotherapy
  • No metastasis evidence was found
  • Annual preservation surgery is available
  • Tolerate to general anesthesia
  • Eastern Cooperative Oncology Group (ECOG) status score between 0 and 1
  • Patients and general anesthesia can understand the clinical trail well and are willing to take part in

Exclusion Criteria:

  • Suffer with other carcinoma synchronous or metachronous in 5 years
  • Multiple primary colon carcinoma
  • Radiation therapy was performed before surgery
  • History of colorectal surgery
  • Combine with acute intestinal obstruction, intestinal bleeding, intestinal perforation and emergency surgery is needed
  • Multiple organs resection surgery is needed
  • Abdominal perineal resection is performed
  • American Society of Anesthesiologists score stage IV to V
  • Pregnant, suckling period or reject to contraception
  • Severe cardiovascular disease, uncontrollable infection or other severe complication
  • Severe mental illness
  • Unable to go through the treatment because of family, society or regional condition
  • Refuse to take part in the trail

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Low ligation with apical lymph node dissection
Left colic artery (LCA) is identified according to the CT 3D-reconstruction, tie the sigmoid artery and superior rectal artery, preserved LCA while low ligation of the inferior mesenteric artery is performed. Lymphadenectomy to the apical lymph nodes (No.253)is performed around the IMA until 2 cm from the aorta. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.
Low ligation with apical lymph node dissection (LAND). Left colic artery (LCA) is identified according to the CT 3D-reconstruction, tie the sigmoid artery and superior rectal artery, preserved LCA while low ligation of the inferior mesenteric artery is performed. Lymphadenectomy to the apical lymph nodes (No.253)is performed around the IMA until 2 cm from the aorta.
Other Names:
  • LAND
ACTIVE_COMPARATOR: High ligation
Open the peritoneum proceeds cephalad towards the duodenojejunal angle of Treitz, and the mesenteric root is incised 1 cm below the inferior margin of the pancreas. The aortomesenteric window is opened wide and the inferior mesenteric vessels are exposed. The IMA is ligated and divided at 2 cm from its origin. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.
High ligation (HL) Open the peritoneum proceeds cephalad towards the duodenojejunal angle of Treitz, and the mesenteric root is incised 1 cm below the inferior margin of the pancreas. The aortomesenteric window is opened wide and the inferior mesenteric vessels are exposed. The IMA is ligated and divided at 2 cm from its origin. The inferior mesenteric vein (IMV) is divided and ligated below the pancreatic margin.
Other Names:
  • HL

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
5-years overall survival rate
Time Frame: 5 years
5-years overall survival rate
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
5-years disease free survival rate
Time Frame: 5 years
5-years disease free survival rate
5 years
1-year overall survival rate
Time Frame: 1 year
1-year overall survival rate
1 year
1-year disease free survival rate
Time Frame: 1 year
1-year disease free survival rate
1 year
Anastomosis leakage rate
Time Frame: 6 months
anastomosis leakage rate after surgery, acute or chronic
6 months
Apical Lymph Nodes (LN) Positive Rate
Time Frame: 1 week
Apical Lymph Nodes Positive Rate, No.253 LN
1 week
Operation Time
Time Frame: 1 day
1 day
Blood loss during operation
Time Frame: 1 day
1 day
Complication incident rate of surgery
Time Frame: 1 day
1 day
conversion rate to laparotomy
Time Frame: 1 day
1 day
Identification of IMA perfusion type before surgery
Time Frame: 1 day
1 day
Identification of lymph node metastasis by CT
Time Frame: 7 days
7 days
Mortality rate in 30 days after surgery
Time Frame: 30 days
30 days
Recovery time after surgery
Time Frame: 60 days
60 days
White cell level
Time Frame: 7 days
7 days
C-reaction protein level
Time Frame: 7 days
7 days
Albumin level
Time Frame: 7 days
7 days
Anastomosis bleeding rate after surgery
Time Frame: 30 days
30 days
Anastomosis stenosis rate after surgery
Time Frame: 30 days
30 days
Intestinal dysfunction after stoma closure
Time Frame: 1 year
1 year
Anus function after surgery
Time Frame: 1 year
1 year
Life quality scoring
Time Frame: 1 year
1 year
Bladder residual urine volume
Time Frame: 1 year
1 year
Sexual function scoring
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Meijin Huang, MD, The Sixth Affiliated Hospital, Sun Yat-sen University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (ANTICIPATED)

December 1, 2018

Study Completion (ANTICIPATED)

December 1, 2023

Study Registration Dates

First Submitted

December 31, 2016

First Submitted That Met QC Criteria

January 5, 2017

First Posted (ESTIMATE)

January 6, 2017

Study Record Updates

Last Update Posted (ESTIMATE)

January 12, 2017

Last Update Submitted That Met QC Criteria

January 11, 2017

Last Verified

December 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • LAND

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rectal Cancer

Clinical Trials on Low ligation with apical lymph node dissection

Search Similar Trials